Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? (Q46088813)

19 December 2017

title

Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? (English)

1 reference

19 December 2017

0 references

0 references

Nielson KA

1

1 reference

19 December 2017

Nolan JH

2

1 reference

19 December 2017

Berchtold NC

3

1 reference

19 December 2017

Sandman CA

4

1 reference

19 December 2017

Mulnard RA

5

1 reference

19 December 2017

Cotman CW

6

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

19 December 2017

Journal of the American Geriatrics Society

published in

1 reference

19 December 2017

volume

44

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

897-904

1 reference

19 December 2017

The Management of Diabetes Mellitus in Older Individuals

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Are Alzheimer patients healthier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Apolipoprotein E and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: a complication of diabetes or a consequence of treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Type II diabetes and cognitive function. A population-based study of Native Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Cognitive function in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1996.TB01857.X

10.1111/J.1532-5415.1996.TB01857.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

8708297

1 reference

19 December 2017